PLX · Categories · Form 4

PLX - SEC Form 4 insider transactions

Protalix BioTherapeutics Inc. (DE) (PLX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PLX

• 203d
  Director Bar-Shalev Amos sold $314 worth of shares (168 units at $1.87), closing all direct ownership in the company (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Forster Eliot was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Boudes Pol F was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Schwartz Aharon was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Melincoff Gwen A was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Bar-Shalev Amos was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Elze Christian was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Sr. VP, Operations Naos Yaron was granted 25,000 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  Director Ben Zvi Shmuel was granted 7,500 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 279d
  PRESIDENT AND CEO Bashan Dror was granted 195,000 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 582d
  Amendment: Sr. VP and CFO Rubin Eyal was granted 90,909 shares (SEC Form 4)

  4/A - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 624d
  SEC Form 4 filed by Sr. VP, Operations Naos Yaron

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 624d
  Sr. VP and CFO Rubin Eyal was granted 99,010 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 798d
  Bashan Dror was granted 263,960 shares (SEC Form 4)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 981d
  SEC Form 4 filed by Boudes Pol F

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 981d
  SEC Form 4 filed by Schwartz Aharon

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 981d
  SEC Form 4 filed by Ben Zvi Shmuel

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 981d
  SEC Form 4 filed by Melincoff Gwen A

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 981d
  SEC Form 4 filed by Bar-Shalev Amos

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 999d
  SEC Form 4 filed by Forster Eliot

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1028d
  SEC Form 4: Bashan Dror was granted 800,000 shares

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1028d
  SEC Form 4: Hayon Yael was granted 35,115 shares

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1028d
  SEC Form 4: Rubin Eyal was granted 201,903 shares

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1028d
  SEC Form 4: Naos Yaron was granted 187,344 shares

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1252d
  SEC Form 4: Schwartz Aharon bought $155,815 worth of shares (110,000 units at $1.42), increasing direct ownership by 172% to 174,000 units

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Naos Yaron

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Ben Zvi Shmuel

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Hayon Yael

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Bashan Dror

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Rubin Eyal

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Schwartz Aharon

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Bronfeld Zeev

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Bar-Shalev Amos

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Melincoff Gwen A

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1370d
  SEC Form 4 filed by Boudes Pol F

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1436d
  SEC Form 4 filed by Ben Zvi Shmuel

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1519d
  SEC Form 4: Bashan Dror bought $102,000 worth of shares (68,000 units at $1.50)

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1563d
  SEC Form 4: Bashan Dror was granted 637,531 shares

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)
• 1833d
  SEC Form 4 filed by Protalix BioTherapeutics, Inc.

  4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)

Other PLX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends